Ralf Bauer

1.5k total citations
46 papers, 906 citations indexed

About

Ralf Bauer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Ralf Bauer has authored 46 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 8 papers in Nephrology. Recurrent topics in Ralf Bauer's work include Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), Cardiomyopathy and Myosin Studies (10 papers) and Muscle Physiology and Disorders (9 papers). Ralf Bauer is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers), Cardiomyopathy and Myosin Studies (10 papers) and Muscle Physiology and Disorders (9 papers). Ralf Bauer collaborates with scholars based in Germany, United Kingdom and United States. Ralf Bauer's co-authors include Hugo A. Katus, Arnt V. Kristen, Fabian aus dem Siepen, Volker Straub, Sebastian J. Buss, A. Blain, Guy A. MacGowan, Matthias Aurich, Selina Hein and Henning Steen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Analytical Biochemistry.

In The Last Decade

Ralf Bauer

44 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Bauer Germany 17 634 330 171 137 103 46 906
Robert R. Fandrich Canada 19 784 1.2× 318 1.0× 25 0.1× 83 0.6× 91 0.9× 41 1.1k
Qiang Sun China 14 339 0.5× 413 1.3× 70 0.4× 131 1.0× 230 2.2× 53 993
Yung‐Wu Chen United States 12 522 0.8× 95 0.3× 55 0.3× 52 0.4× 60 0.6× 24 963
Clément E. Tagoe United States 18 623 1.0× 61 0.2× 154 0.9× 47 0.3× 169 1.6× 39 944
Tomoaki Higo Japan 12 356 0.6× 253 0.8× 51 0.3× 77 0.6× 47 0.5× 21 678
Mahnaz Bonrouhi Germany 14 493 0.8× 35 0.1× 91 0.5× 127 0.9× 114 1.1× 21 947
Baoqi Yu China 22 475 0.7× 135 0.4× 24 0.1× 126 0.9× 61 0.6× 32 950
Ana Ortega Spain 18 594 0.9× 239 0.7× 43 0.3× 24 0.2× 26 0.3× 45 851
Mohga El‐Abbadi United States 14 439 0.7× 47 0.1× 367 2.1× 99 0.7× 69 0.7× 15 1.1k
Nour‐Eddine Rhaleb United States 19 408 0.6× 207 0.6× 25 0.1× 40 0.3× 110 1.1× 39 963

Countries citing papers authored by Ralf Bauer

Since Specialization
Citations

This map shows the geographic impact of Ralf Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Bauer more than expected).

Fields of papers citing papers by Ralf Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Bauer. The network helps show where Ralf Bauer may publish in the future.

Co-authorship network of co-authors of Ralf Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Bauer. A scholar is included among the top collaborators of Ralf Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Bauer. Ralf Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Ralf, Andreas Jungmann, Barbara Leuchs, et al.. (2018). Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice. Neuromuscular Disorders. 29(3). 231–241. 10 indexed citations
2.
Tilemann, Lisa, Ralf Bauer, Markus Heckmann, et al.. (2018). AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload. Gene Therapy. 25(1). 13–19. 10 indexed citations
3.
Siepen, Fabian aus dem, Ralf Bauer, Selina Hein, et al.. (2017). Predictors of survival stratification in patients with wild-type cardiac amyloidosis. Clinical Research in Cardiology. 107(2). 158–169. 50 indexed citations
4.
Heckmann, Markus, Ralf Bauer, Andreas Jungmann, et al.. (2016). AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice. Gene Therapy. 23(8-9). 673–679. 10 indexed citations
5.
Blanck, Oliver, M Chan, Ralf Bauer, et al.. (2016). Treatment Planning Considerations for Robotic Guided Cardiac Radiosurgery for Atrial Fibrillation. Cureus. 8(7). e705–e705. 26 indexed citations
6.
Bauer, Ralf, et al.. (2015). Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Kristen, Arnt V., Fabian aus dem Siepen, Katrin Scherer, et al.. (2015). Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging. Amyloid. 22(2). 132–141. 22 indexed citations
8.
Siepen, Fabian aus dem, Ralf Bauer, Matthias Aurich, et al.. (2015). Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study. Drug Design Development and Therapy. 9. 6319–6319. 66 indexed citations
9.
Kristen, Arnt V., Katrin Scherer, Sebastian J. Buss, et al.. (2014). Noninvasive Risk Stratification of Patients With Transthyretin Amyloidosis. JACC. Cardiovascular imaging. 7(5). 502–510. 51 indexed citations
10.
Bauer, Ralf, Nicola Dikow, Andreas Bräuer, et al.. (2014). The “Wagshurst study”: p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy. Amyloid. 21(4). 267–275. 10 indexed citations
11.
Clemen, Christoph S., Florian Stöckigt, Karl-Heinz Strucksberg, et al.. (2014). The toxic effect of R350P mutant desmin in striated muscle of man and mouse. Acta Neuropathologica. 129(2). 297–315. 56 indexed citations
12.
Fullard, Nicola, Paul A. Townsend, Christopher P. Fox, et al.. (2011). The NF-κB Subunit c-Rel Stimulates Cardiac Hypertrophy and Fibrosis. American Journal Of Pathology. 180(3). 929–939. 68 indexed citations
13.
Bauer, Ralf, A. Blain, Elizabeth Greally, et al.. (2010). Intolerance to β-Blockade in a Mouse Model of δ-Sarcoglycan-Deficient Muscular Dystrophy Cardiomyopathy. European Journal of Heart Failure. 12(11). 1163–1170. 14 indexed citations
14.
Bauer, Ralf, Volker Straub, A. Blain, Kate Bushby, & Guy A. MacGowan. (2009). Contrasting Effects of Steroids and Angiotensin-Converting-Enzyme Inhibitors in a Mouse Model of Dystrophin-Deficient Cardiomyopathy. European Journal of Heart Failure. 11(5). 463–471. 52 indexed citations
15.
Rutschow, Désirée, Ralf Bauer, Stefanie Schinkel, et al.. (2009). Prevention of cardiomyopathy in  -sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovascular Research. 82(3). 404–410. 45 indexed citations
16.
Bauer, Ralf, A. Blain, Elizabeth Greally, et al.. (2009). Attenuation of adverse cardiac effects in prednisolone-treated δ-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism. Neuromuscular Disorders. 20(1). 21–28. 9 indexed citations
17.
Bauer, Ralf, Guy A. MacGowan, A. Blain, Kate Bushby, & Volker Straub. (2008). Steroid treatment causes deterioration of myocardial function in the  -sarcoglycan-deficient mouse model for dilated cardiomyopathy. Cardiovascular Research. 79(4). 652–661. 29 indexed citations
18.
Bauer, Ralf, Christoph Dehnert, Arthur Filusch, et al.. (2007). Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respiratory Medicine. 101(11). 2366–2369. 83 indexed citations
19.
Böhm, Ingrid & Ralf Bauer. (1997). Behandlung des bullösen Pemphigoids mit Low-dose-Methotrexat. Der Hautarzt. 48(12). 910–914. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert R. Fandrich Breakdown of academic impact, for papers by Qiang Sun Breakdown of academic impact, for papers by Yung‐Wu Chen Breakdown of academic impact, for papers by Clément E. Tagoe Breakdown of academic impact, for papers by Tomoaki Higo Breakdown of academic impact, for papers by Mahnaz Bonrouhi Breakdown of academic impact, for papers by Baoqi Yu Breakdown of academic impact, for papers by Ana Ortega Breakdown of academic impact, for papers by Mohga El‐Abbadi Breakdown of academic impact, for papers by Nour‐Eddine Rhaleb
Rankless by CCL
2026